Dr. Aalok Kumar is a respected Medical Oncologist whose leadership, clinical expertise, and compassion have shaped cancer care across British Columbia. He currently serves as Department Head of Medical Oncology at BC Cancer Surrey and as a Clinical Assistant Professor within the Faculty of Medicine at the University of British Columbia.

With a clinical focus on breast and gynecologic malignancies, Dr. Kumar is recognized for his depth of knowledge in complex systemic therapies and emerging targeted treatments. As the Provincial Systemic Therapy Chair for Gynecologic Oncology and a longstanding member of the Provincial Breast Cancer Systemic Therapy Committee, he plays a key role in developing evidence-based treatment strategies and fostering multidisciplinary collaboration for patients across the province.

Beyond his clinical practice, Dr. Kumar is deeply committed to medical education. As the Provincial Director of Career Planning for UBC’s MD Undergraduate Program, he developed and leads a comprehensive career-exploration curriculum that supports medical students across all four years of training. His passion for teaching extends to oncology residents, fellows, and nursing colleagues, where he has established several educational programs—including the widely adopted Resident Summer Series.

Dr. Kumar is also a dedicated researcher and clinical trialist. He serves as the provincial or site lead for multiple national and international breast and gynecologic cancer trials, including studies evaluating novel antibody-drug conjugates and oral SERDs for early-stage and metastatic breast cancer. His commitment to research ensures that patients in British Columbia have access to cutting-edge therapies close to home.

A strong advocate for equitable cancer care, Dr. Kumar has worked extensively to address disparities in genetic testing—particularly among patients of South Asian descent. Recognizing the cultural and linguistic barriers that prevent many from accessing preventive care, he has led community-focused awareness initiatives to promote timely and informed genetic testing. His efforts continue to drive system-level improvements that help ensure all patients benefit from advances in precision oncology.

Dr. Kumar’s impact extends far beyond his clinic. Through his advocacy, leadership, and dedication to research-driven care, he continues to champion progress in cancer treatment and to elevate the standard of care for patients with breast cancer throughout British Columbia and Canada.